心血管合并症对哮喘全疾病谱临床结局的影响
本研究基于两个独立前瞻性队列,分析心血管疾病(CVD)对哮喘患者临床结局的影响。队列I纳入1058例稳定期哮喘患者随访12个月,队列II纳入825例因急性加重住院患者。结果显示CVD独立关联严重急性加重(调整IRR=1.96,95%CI 1.12-3.44)、住院和急诊就诊,并与更长住院时间(调整IRR=1.14,95%CI 1.01-1.30)和更高直接费用相关。
要点
- CVD与哮喘患者严重急性加重风险独立相关(调整IRR=1.96)。
- CVD与急性加重住院患者住院时间延长和直接费用增加相关。
- CVD患者气流受限更重且呈非T2炎症特征,中性粒细胞炎症增加。
核心结论
- CVD是哮喘全疾病谱中独立关联更差临床结局的合并症。
- 研究支持将CVD视为哮喘重要的可治疗特征,并强调心肺整合管理的必要性。
研究设计与样本
- 分析两个独立前瞻性队列:队列I为1058例稳定期哮喘患者(CVD n=107,非CVD n=951),随访12个月评估急性加重。
- 队列II为825例因急性加重住院的哮喘患者(CVD n=233,非CVD n=592)。
- 缺失数据采用多重插补处理,CVD组与非CVD组采用倾向评分重叠加权平衡。
- 关联估计使用负二项、伽马和逻辑回归;中介分析和优势分析作为探索性分析。
主要发现
- CVD患者表现出更严重的气流阻塞和以中性粒细胞炎症增加为主的非T2炎症特征。
- 白细胞、中性粒细胞和单核细胞部分中介CVD与较低FEV1/FVC比值之间的关联。
- 单核细胞还中介CVD与严重急性加重之间的关联。
- 队列I中,CVD独立关联严重急性加重(调整IRR=1.96,95%CI 1.12-3.44)、住院和急诊就诊。
- 队列II中,CVD关联更长住院时间(调整IRR=1.14,95%CI 1.01-1.30)和更高直接费用,卒中和冠心病是住院时间延长的主要贡献因素。
关键数值与推荐
- 队列I中CVD与严重急性加重的调整IRR=1.96(95%CI 1.12-3.44)。
- 队列II中CVD与更长住院时间的调整IRR=1.14(95%CI 1.01-1.30)。
临床怎么用
- 对哮喘患者应评估心血管合并症,将其作为可治疗特征进行管理。
- 对合并CVD的哮喘患者,需关注严重急性加重、住院和急诊就诊风险。
- 对因急性加重住院的CVD患者,应预期更长住院时间和更高费用,并加强心肺整合管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Cardiovascular disease (CVD) is a prevalent comorbidity in asthma, yet its impact on clinical outcomes across disease states remains poorly characterised. METHODS: We analysed data from two independent prospective cohorts. Cohort I comprised 1058 stable asthma patients (CVD: n = 107; non-CVD: n = 951) followed for 12 months to assess asthma exacerbations. Cohort II comprised 825 patients hospitalised for an acute exacerbation (CVD: n = 233; non-CVD: n = 592). Missing data were handled by multiple imputation, and the CVD and non-CVD groups were balanced using propensity score overlap weighting. Associations were estimated using negative binomial, gamma, and logistic regression. Mediation and dominance analyses were performed as exploratory analyses. RESULTS: Patients with CVD exhibited greater airflow obstruction and a predominantly non-T2 inflammatory profile characterised by increased neutrophilic inflammation. White blood cells, neutrophils, and monocytes partially mediated the association between CVD and lower FEV1/FVC ratio, while monocytes additionally mediated the association between CVD and severe exacerbations. In Cohort I, CVD was independently associated with severe exacerbations (adjusted IRR = 1.96, 95% CI (1.12, 3.44)), hospitalisations, and emergency visits. In Cohort II, CVD was associated with longer hospital stay (adjusted IRR = 1.14, 95% CI (1.01, 1.30)) and higher direct costs, with stroke and coronary heart disease as leading contributors to prolonged stay. CONCLUSION: CVD is independently associated with worse clinical outcomes across the asthma disease spectrum. These findings support recognition of CVD as an important treatable trait in asthma and highlight the need for integrated cardiopulmonary management.
引用
- Wu WW, Wang J, Ma WAQ, et al. Impact of Cardiovascular Comorbidities on Clinical Outcomes Across the Asthma Spectrum. Respirology. 2026. PMID: 42764581. doi:10.1002/resp.70317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。